Draper L - Search Results

1

Robust cross-cohort gut microbiome associations with COVID-19 severity.

Li J, Ghosh TS, McCann R, Mallon P, Hill C, Draper L, Schult D, Fanning LJ, Shannon R, Sadlier C, Horgan M, O'Mahony L, O'Toole PW. Li J, et al. Among authors: draper l. Gut Microbes. 2023 Jan-Dec;15(1):2242615. doi: 10.1080/19490976.2023.2242615. Gut Microbes. 2023. PMID: 37550964 Free PMC article.

2

Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147.

Cotter PD, O'Connor PM, Draper LA, Lawton EM, Deegan LH, Hill C, Ross RP. Cotter PD, et al. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18584-9. doi: 10.1073/pnas.0509371102. Epub 2005 Dec 8. Proc Natl Acad Sci U S A. 2005. PMID: 16339304 Free PMC article.

3

Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

Cotter PD, Draper LA, Lawton EM, McAuliffe O, Hill C, Ross RP. Cotter PD, et al. Appl Environ Microbiol. 2006 Jun;72(6):4492-6. doi: 10.1128/AEM.02543-05. Appl Environ Microbiol. 2006. PMID: 16751576 Free PMC article.

4

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.

Cotter PD, Deegan LH, Lawton EM, Draper LA, O'Connor PM, Hill C, Ross RP. Cotter PD, et al. Mol Microbiol. 2006 Nov;62(3):735-47. doi: 10.1111/j.1365-2958.2006.05398.x. Mol Microbiol. 2006. PMID: 17076667 Free article.

5

Lantibiotic immunity.

Draper LA, Ross RP, Hill C, Cotter PD. Draper LA, et al. Curr Protein Pept Sci. 2008 Feb;9(1):39-49. doi: 10.2174/138920308783565750. Curr Protein Pept Sci. 2008. PMID: 18336322 Review.

6

Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes.

Cotter PD, Draper LA, Lawton EM, Daly KM, Groeger DS, Casey PG, Ross RP, Hill C. Cotter PD, et al. PLoS Pathog. 2008 Sep 12;4(9):e1000144. doi: 10.1371/journal.ppat.1000144. PLoS Pathog. 2008. PMID: 18787690 Free PMC article.

7

Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147.

Draper LA, Grainger K, Deegan LH, Cotter PD, Hill C, Ross RP. Draper LA, et al. Mol Microbiol. 2009 Feb;71(4):1043-54. doi: 10.1111/j.1365-2958.2008.06590.x. Epub 2009 Jan 16. Mol Microbiol. 2009. PMID: 19183281 Free article.

8

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.

Piper C, Draper LA, Cotter PD, Ross RP, Hill C. Piper C, et al. J Antimicrob Chemother. 2009 Sep;64(3):546-51. doi: 10.1093/jac/dkp221. Epub 2009 Jun 26. J Antimicrob Chemother. 2009. PMID: 19561147

9

Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.

Carroll J, Draper LA, O'Connor PM, Coffey A, Hill C, Ross RP, Cotter PD, O'Mahony J. Carroll J, et al. Int J Antimicrob Agents. 2010 Aug;36(2):132-6. doi: 10.1016/j.ijantimicag.2010.03.029. Epub 2010 May 23. Int J Antimicrob Agents. 2010. PMID: 20547041

10

Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.

Deegan LH, Suda S, Lawton EM, Draper LA, Hugenholtz F, Peschel A, Hill C, Cotter PD, Ross RP. Deegan LH, et al. Microb Biotechnol. 2010 Mar;3(2):222-34. doi: 10.1111/j.1751-7915.2009.00145.x. Epub 2009 Aug 23. Microb Biotechnol. 2010. PMID: 21255322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page